Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107

Timmerman, 2009, Local surgical, ablative, and radiation treatment of metastases, CA Cancer J Clin, 59, 145, 10.3322/caac.20013

Zlotnik, 2011, Homeostatic chemokine receptors and organ-specific metastasis, Nat Rev Immunol, 11, 597, 10.1038/nri3049

Koizumi, 2007, Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response, Cancer Sci, 98, 1652, 10.1111/j.1349-7006.2007.00606.x

Koizumi, 2012, Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer, Front Biosci (Schol Ed), 4, 269, 10.2741/s267

Matloubian, 2000, A transmembrane CXC chemokine is a ligand for HIV coreceptor Bonzo, Nat Immunol, 1, 298, 10.1038/79738

Shimaoka, 2000, Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages, J Biol Chem, 275, 40663, 10.1074/jbc.C000761200

Wilbanks, 2001, Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines, J Immunol, 166, 5145, 10.4049/jimmunol.166.8.5145

Abel, 2004, The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10, J Immunol, 172, 6362, 10.4049/jimmunol.172.10.6362

Gough, 2004, A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16, J Immunol, 172, 3678, 10.4049/jimmunol.172.6.3678

Ludwig, 2005, Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules, Comb Chem High Throughput Screen, 8, 161, 10.2174/1386207053258488

Gutwein, 2008, Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients, Eur J Cancer, 10, 1016

Lu, 2008, CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro, Mol Cancer Res, 6, 546, 10.1158/1541-7786.MCR-07-0277

Darash-Yahana, 2009, The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers, Plos One, 4, e6695, 10.1371/journal.pone.0006695

Hojo, 2007, High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer, Cancer Res, 67, 4725, 10.1158/0008-5472.CAN-06-3424

Wågsäter, 2004, Expression of CXCL16 in human rectal cancer, Int J Mol Med, 14, 65

Wente, 2008, Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma, Int J Oncol, 33, 297

Ou, 2006, Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy, J Pathol, 210, 363, 10.1002/path.2053

Held-Feindt, 2008, Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas, Glia, 56, 764, 10.1002/glia.20651

Seidl, 2007, Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma, Human Pathol, 38, 768, 10.1016/j.humpath.2006.11.013

Kim, 2001, Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential, J Clin Invest, 107, 595, 10.1172/JCI11902

Kim, 2002, Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity, Blood, 100, 11, 10.1182/blood-2001-12-0196

Taniguchi, 2003, The regulatory role of Valpha14 NKT cells in innate and acquired immune response, Annu Rev Immunol, 21, 483, 10.1146/annurev.immunol.21.120601.141057

Cui, 1997, Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors, Science, 278, 1623, 10.1126/science.278.5343.1623

Kawano, 1998, Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells, Proc Natl Acad Sci USA, 95, 5690, 10.1073/pnas.95.10.5690

Toura, 1999, Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide, J Immunol, 163, 2387, 10.4049/jimmunol.163.5.2387

Smyth, 2000, Differential tumor surveillance by natural killer (NK) and NKT cells, J Exp Med, 191, 661, 10.1084/jem.191.4.661

Cullen, 2009, Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation, J Immunol, 183, 5807, 10.4049/jimmunol.0803520

Nakagawa, 2001, Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice, J Immunol, 166, 6578, 10.4049/jimmunol.166.11.6578

Smyth, 2002, Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide, Blood, 99, 1259, 10.1182/blood.V99.4.1259

Tachibana, 2005, Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas, Clin Cancer Res, 11, 7322, 10.1158/1078-0432.CCR-05-0877

Thomas, 2003, CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells, J Immunol, 171, 2571, 10.4049/jimmunol.171.5.2571

Johnston, 2003, Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets, J Immunol, 171, 2960, 10.4049/jimmunol.171.6.2960

Geissmann, 2005, Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids, PLoS Biol, 3, e113, 10.1371/journal.pbio.0030113

Germanov, 2008, Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells, J Immunol, 181, 81, 10.4049/jimmunol.181.1.81

Ha, 2011, Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer, Mol Med Rep, 4, 419

Guo, 2011, Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma, Chin J Cancer, 30, 336, 10.5732/cjc.010.10490

Lombardi, 2010, A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity, J Immunol, 184, 2107, 10.4049/jimmunol.0901208

Sato, 2005, Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver, J Immunol, 174, 277, 10.4049/jimmunol.174.1.277

Heydtmann, 2005, CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver, J Immunol, 174, 1055, 10.4049/jimmunol.174.2.1055

Wang, 2008, CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer, Hum Immunol, 69, 811, 10.1016/j.humimm.2008.08.276

Slettenaar, 2006, The chemokine network: a target in cancer biology?, Adv Drug Deliv Rev, 58, 962, 10.1016/j.addr.2006.03.012